Skinbiotherapeutics PLC (SBTX) Share Price & Analysis

Open: 11.25
High: 12.50
Low: 11.40
Close: 12.14
Change: +0.75 (6.67%)
Volume: 1,102,404

16 Dec 2025	Annual Report and Accounts (to 2025-06-30)
17 Dec 2024	Annual Report and Accounts (to 2024-06-30)
12 Dec 2023	Annual Report and Accounts (to 2023-06-30)

Martin HuntExecutive Chairman

–

Alyson Margaret LevettInterim Chair

5 mos

Rachel Lisa ParsonageInterim Chief Executive Officer

3 mos

Emily BertramChief Financial Officer

–

Dr Cathy PrescottNon-Executive Director

–

SkinBioTherapeutics is a biotech firm that specializes in enhancing skin wellness. The company's unique SkinBiotix® technology is built on the research findings of Professor Catherine O'Neill and Professor Andrew McBain.

Industry: Health Care
Sector: Health Care
LEI: 213800YMQOCB23FX6I06
Region: Europe
Admission date: 5 Apr 2017
Website: www.skinbiotherapeutics.com
X: @SkinBioT

Shares in issue: 259,168,671
Total Voting Rights: 259,168,671

Last updated: 26 June 2026

Open: 11.25
High: 12.50
Low: 11.40
Close: 12.14
Change: +0.75 (6.67%)
Volume: 1,102,404

16 Dec 2025	Annual Report and Accounts (to 2025-06-30)
17 Dec 2024	Annual Report and Accounts (to 2024-06-30)
12 Dec 2023	Annual Report and Accounts (to 2023-06-30)

Martin HuntExecutive Chairman

–

Alyson Margaret LevettInterim Chair

5 mos

Rachel Lisa ParsonageInterim Chief Executive Officer

3 mos

Emily BertramChief Financial Officer

–

Dr Cathy PrescottNon-Executive Director

–

Industry: Health Care
Sector: Health Care
LEI: 213800YMQOCB23FX6I06
Region: Europe
Admission date: 5 Apr 2017
Website: www.skinbiotherapeutics.com
X: @SkinBioT

Shares in issue: 259,168,671
Total Voting Rights: 259,168,671

Last updated: 26 June 2026

ISIN: GB00BF33H870
Exchange: AIMX
Market: Aim
Market Segment: ASQ1
Market Sector: AMQ1

ISIN: GB00BF33H870
Exchange: AIMX
Market: Aim
Market Segment: ASQ1
Market Sector: AMQ1

25 Jun 2026	12:00:00	Directorate change
23 Jun 2026	12:03:41	Notice of Investor Presentation
8 Jun 2026	07:30:01	Restoration - SkinBioTherapeutics PLC
8 Jun 2026	07:00:10	Half-year Results (HY26) and Restated FY25 Results

21 Jun 2026	AIM weekly movers: Qunatum Helium confirms helium concentrations and discovers oil	UK Investor Magazine
16 Jun 2026	AIM movers: Tatton Asset Management continues to beat expectations and Everyman Media wants to leave AIM	UK Investor Magazine

25 Jun 2026	12:00:00	Directorate change
23 Jun 2026	12:03:41	Notice of Investor Presentation
8 Jun 2026	07:30:01	Restoration - SkinBioTherapeutics PLC
8 Jun 2026	07:00:10	Half-year Results (HY26) and Restated FY25 Results

21 Jun 2026	AIM weekly movers: Qunatum Helium confirms helium concentrations and discovers oil	UK Investor Magazine
16 Jun 2026	AIM movers: Tatton Asset Management continues to beat expectations and Everyman Media wants to leave AIM	UK Investor Magazine

Skinbiotherapeutics PLC

Skinbiotherapeutics PLC

Price Chart

Recent RNS announcements

Annual Reports

Directors (7)

In the Press

Company details

Shares details